Summary -

Key Takeaways Explained for a Non-Medical Audience

– The hyperinsulinemic euglycemic clamp and intravenous glucose tolerance test are the most reliable reference methods for measuring insulin sensitivity.

– Simpler indices have been developed for broader use, derived from fasting measurements or oral glucose tolerance test data.

– HOMA‑IR, QUICKI, and Matsuda index are suitable for clinical applications due to their simplicity and validation.

– Research and epidemiological use may favor other indices such as HES, McAuley, Belfiore, Cederholm, Avignon, and Stumvoll.

– Each index reflects different aspects of insulin and glucose dynamics, influenced by insulin levels, glucose levels, and sometimes adiposity.

– Reliability and applicability of these indices vary depending on the population and study design.

– Clinicians must carefully select the insulin resistance index appropriate for their setting and objective.

– Overabundance of available indices may lead to confusion without clear guidelines for selection.

– Validation against the gold‑standard clamp method is essential to establish an index’s utility.

– Indices based on fasting measures may miss early metabolic dysfunction evident during glucose challenges.

– OGTT‑derived indices can capture dynamic response patterns and provide deeper insight into insulin metabolism.

– The choice of index affects early detection and management of insulin resistance and metabolic dysfunction.

– Standardized, validated indices enable better monitoring of metabolic health and response to interventions.

– Awareness of index limitations ensures more accurate application in both research and clinical contexts.

– Early and accurate assessment of insulin resistance underpins effective preventative metabolic strategies.